USA to Support Vaccine Intellectual Property Waiver - COVID-19 Update - WHO (07 May 2021)

The United Nations of Earth reporting on this issue: "USA to Support Vaccine Intellectual Property Waiver - COVID-19 Update - WHO (07 May 2021)"
The topics: The US announcement to support a temporary waiver of intellectual property protections for COVID-19 vaccines is “a significant statement of solidarity and support for vaccine equity,” WHO chief Dr Tedros Ghebreyesus said on Friday (7 May), urging other countries “to follow their example." "We are in an unprecedented crisis that requires unprecedented action,” Dr Tedros said. “Cases are at a record high, almost 100,000 people are dying globally each week, and we have a chronic vaccine crisis.” Insisting that the World Trade Organization provisions for Intellectual Property waivers were designed “precisely for a situation like this,” Dr Tedros asked, “if we don’t use them now, then when?” He also reminded that intellectual property waivers will need to be accompanied by transfer of technology and know-how for these difficult-to-make vaccines. Announcing the WHO’s Emergency Use Listing to Sinopharm Beijing’s COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality, Dr Tedros said “the Strategic Advisory Group of Experts on Immunization, or SAGE, has also reviewed the available data, and recommends the vaccine for adults 18 years and older, with a two-dose schedule.” “Vaccines remain a vital tool,” Dr Tedros said. “But right now, the volume and distribution of vaccines is insufficient to end the pandemic, without the sustained and tailored application of public health measures that we know work."


Click here for more information, to subscribe to the channel of United Nations or to watch the video on YouTube.